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A B S T R A C T
In this study we reported the results for the first time of applying Polymerase Chain Reaction-Short Tandem Repeats
(PCR-STR) method in the field of detection of aneuploidies for chromosomes 21 and 18 in Croatians. The aims of the
study were: (I) validation of the diagnostic informativeness of 6 STR loci (D18S51, D18S858, D18S535, D21S1435,
D21S1411, and D21S1414) in sample of 205 unrelated healthy individuals; (II) evaluation of diagnostic power of the
PCR-STR method for those 6 microsatellites; (III) establishment protocol for use STRs as routine method for rapid pre-
natal detection of trisomy 21 and 18. DNA samples were amplified by fluorescence-based PCR reaction, subjected to elec-
trophoresis in automated laser fluorescence DNA sequencer (ALFexpress). Results of our study were: (I) all 6 tested loci
are informative (68–85% of heterozygous individuals); (II) comparison between PCR-STR method and conventional
cytogenetics did not revealed any false positive or false negative results; (III) in prenatal screening of 105 samples of un-
cultured amniotic fluid 6 (5.7%) samples with chromosomal abnormalities were identified.
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Introduction
Prenatal diagnosis of chromosomal aneuploidies is
routinely accomplished by standard cytogenetic tech-
niques. Prenatal diagnosis of trisomy 21 and 18 is usually
performed using in vitro cultures of amniocytes or chori-
onic cellular cells, followed by the analysis of metaphases
stained by conventional procedures1,2. The main disad-
vantage of these procedures is that definitive results can
be obtained only after 2–3 weeks of in vitro cultures which
delays the time of diagnosis and requires high costs.
During 1978–2001, a total of 17 004 routine prenatal
cytogenetic diagnosis have been performed in our De-
partment and 314 (2.00%) aneuploidies were detected.
Trisomy 21 was detected in 181 (1.06%) cases, 54 (0.32%)
cases had trisomy 18 and 11 (0.07%) cases of aneuploidy
was detected as trisomy 133.
An alternative rapid method which is suitable for di-
agnosing trisomies, fluorescent polymerase chain reac-
tion using polymorphic short tandem repeats (STRs)
have been proposed4–7. Namely, the human genome con-
tains many repeated DNA sequences, which can be wi-
dely dispersed or in short tandem arrays. STRs are short
sequences of DNA, usually 2–5 base pairs in length that
are repeated numerous times.
Aims of this study were: (I) to validate the diagnostic
informativeness of 6 STR loci D18S51, D18S858, D18-
S535, D21S1435, D21S1411, and D21S1414) in a sample
of 205 unrelated healthy individuals; (II) to evaluate di-
agnostic power of the PCR-STR method for those 6
microsatellite loci; (III) to establish protocol for usage of
PCR-STR as routine method for rapid prenatal detection
of trisomy 21 and 18.
Materials and Methods
Genomic DNA, from 205 unrelated healthy individu-
als for population study, was isolated from peripheral
blood leukocytes by NucleoSpin Blood isolation kit8.
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Six hundred and thirty-four amniotic fluid samples
were previously tested by conventional cytogenetic anal-
ysis. In this group, twenty-two trisomic samples (trisomy
21 or trisomy 18) were also analysed by PCR-STR me-
thod. DNA of these samples was isolated from cultured
cells by the same isolation kit.
One hundred and five amniotic fluid samples were
tested blind using PCR-STR method. Samples were col-
lected from pregnant women who underwent amniocente-
sis for prenatal chromosome analysis between gestational
weeks 16 and 20. The referral criteria were maternal age
(38 years), positive biochemical screening for Down syn-
drome and abnormal fetal ultrasonographic scan. DNA
from 5 ml uncultured amniotic fluid was also extracted
using NucleoSpin Blood isolation kit.
Amplification of samples was performed in a total
volume of 11.5ml in Mastercycler gradient thermocyler
(Eppendorf-Germany). The primers’ sequences were as
follows: for D18S51 5’gagccatgttcatgccactg, 3’caaaccc-
gactaccagcaac; for D18S858 5’agctggagagggatagcatt,
3’tgcattgcatgaaagtagga; for D18S535 5’tcatgtgacaaaa-
gccacac, 3’agacagaaatatagatgagaatgca; for D21S1435
5’ccctctcaattgtttgtctacc, 3’gcaagagatttcagtgccat; for D21-
S1411 5’atgatgaatgcatagatggatg, 3’cccagccctctaaatatcatcc;
and for D21S1414 5’aaattagtgtctggcacccagta, 3’caatt-
ccccaagtgaattgccttc. The PCR amplification conditions
were the following: for D18S51, D18S535 and D21S1435:
95°C-30’’; 53°C-1’; 72°C-30’’ (35x); for D18S858, D21S1411,
and for D21S1414: 94°C-30’’; 55°C-1’15’’; 72°C-15’’ (27x).
After amplification, the PCR products (1.5ml) were
mixed with 3ml of loading buffer and 1ml of each of two in-
ternal size markers. On each gel we also included one ex-
ternal, commercial sizer. Electrophoresis was performed
using a 6% standard denaturing polyacrylamide gel in an
automated laser fluorescence DNA sequencer (ALFex-
press, Pharmacia Biotech, Uppsala, Sweden). The ampli-
fication products were analysed and their relative fluo-
rescent intensities calculated using Fragment Manager
software (Pharmacia Biotech). The patterns obtained by
the analysis were the following: for the normal subjects
two peaks with 1:1 ratio or one single peak; for trisomic
cases three peaks with ratio 1:1:1 or two peaks with 2:1
ratio or single peak in the case of homozygosity. Polymor-
phism information content (PIC) value was obtained as
suggested by Hearne9.
Results and Discussion
Population study (N=205) confirmed that all six STR
loci are informative in the Croatian population, which is
also the case for the other populations so far report-
ed10–13.
The observed frequencies of heterozygotes are in con-
cordance with the expected frequencies for all tested loci,
PIC value was also calculated and revealed that these
systems have a high PIC value (Table1). With respect to
the observed heterozygosity and PIC value they can be
used in detection of aneuploidies. However, this and pre-
vious studies also showed that STR loci have a relatively
high instability of their alleles and a high level of muta-
tion in comparison with other genetic markers14. For
that reason, the occurrence of the intermediate alleles
(differ by 2bp instead of 4bp) is frequent and it can lead
to problems in the case of distinguishing heterozygosity
and homozygosity. Therefore we used 3 STR loci for each
chromosome.
Among 634 samples of amniotic fluid successfully pro-
cessed, trisomies 21 were diagnosed by standard cyto-
genetic methods in 19 cases while trisomy 18 was ob-
served in 3 cases. For each amniotic fluid sample with
trisomy, we also performed amnio-PCR analysis by ampli-
fying STR markers on chromosome 21 and chromosome
18, respectively. The results of testing the samples with
trisomy 21 using three STR loci (D21S1435, D21S1411,
and D21S1414) are shown in Table 2. In diagnosis of
Down’s syndrome the most informative were D21S1414
and D21S1435 loci, while at the same time D21S1411
showed homozygosity in three cases. Diagnosis of Ed-
ward’s syndrome was always successful with D18S51 and
D18S535 loci, while D18S858 locus was not informative
in one case. Comparison study between conventional
cytogenetic analysis and PCR-STRmethod in a sample of
22 amniotic fluids did not reveal false positive or false
negative results.
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TABLE 1
STATISTICAL PARAMETERS FOR STR MARKERS D18S51,
D18S535, D18S858, D21S1435, D21S1411 AND D21S1414 OBTAINED
FROM POPULATION STUDY (N=205)
Marker Ob.H Ex.H PIC
D18S51 0.81 0.90 0.91
D18S535 0.74 0.77 0.78
D18S858 0.68 0.83 0.82
D21S1435 0.76 0.96 0.77
D21S1411 0.85 0.99 0.89
D21S1414 0.76 0.93 0.93
Ob.H – observed heterozygosity, Ex.H – expected heterozygosity,
PIC – polymorphism information content
TABLE 2
RESULTS OF TRISOMIC SAMPLES TESTED FOR TRISOMY 18
AND TRISOMY 21 PARALLEL BY PCR-STR METHOD
AND CLASSICAL CYTOGENETIC
Samples
(N=22)
STR
locus
Triallelic
pattern
(No)
Diallelic
pattern
(No)
Monoallelic
pattern
(No)
Trisomy 18
(N=3)
D18S51 2 1 0
D18S535 1 2 0
D18S858 1 1 1
Trisomy 21
(N=19)
D21S1435 11 8 0
D21S1411 8 8 3
D21S1414 14 5 0
No – number of occurence
We performed prenatal screening of 105 amniotic
fluid samples taken from women who matched one of the
three criteria listed in Material and Methods. Among
these samples, 6 (5.7%) autosomal anomalies were iden-
tified by PCR-STR method (Table 3). All anomalies were
also subsequently verified by conventional karyotyping.
Trisomy 21 was diagnosed in four cases; in one case we
detected trisomy 18, while the last anomaly was shown to
be triploidy. There were also no false positive or false
negative results in comparison to classical cytogentics.
However, from our experience PCR-STR cannot com-
pletely replace conventional karyotyping due to the pos-
sible chromosomal abnormalities other than most common
trisomies. On the other hand, conventional karyotyping
ideally takes 3–4 weeks but due to the limited resources
available for this procedure in Croatia, it can last up to 5
weeks. Use of PCR-STRmethod as a screening procedure
can give results within 3 days and therefore reduce pa-
rental anxiety but also can point out which samples
should be given priority in standard procedure, namely,
those cases where the PCR-STR analysis has discovered
an aneuploidy. This is necessary because our protocol
does not follow the policy of terminating the pregnancy
on the base of the PCR-STR analysis results without
waiting for the conventional cytogenetic confirmation as
is the case in some other centres.15 In this aspect, our
protocol is similar to protocols suggested by Andonova et
al.16 We would also like to emphasize that compared to
the other fast reporting technique for analysis of am-
niotic fluid – interphase fluorescence in situ hybridisa-
tion, PCR-STR method is less labour intensive.
At the same time, it is important to mention that
PCR-STR technique can not always detect mosaics,
translocations and deletion or duplication syndromes
which is possible to detect by conventional cytogenetic
analysis. The use of a larger panel of STR markers which
cover wider regions of chromosome as well as those lo-
cated on the other key chromosomes will improve the de-
tection rate of PCR-STR technique in future.
Furthermore, one of the advantages of this method is
also the possibility of determination of maternal or pa-
ternal origin of chromosomal aneuploidies17. During our
study we had one family with three children, two of them
had trisomy 21 Molecular analysis showed that one child
inherited supernumerary chromosome 21 from mother,
while second child with Down’s syndrome inherited su-
pernumerary chromosome 21 from father.
This investigation also included one case of mosaicism
involving chromosome 18. When tested by D18S535 this
sample showed unexpected triallelic pattern (all peaks
were not equal – 3.5:1:3.5), while the rest of two STR loci
for chromosome 18 showed two allelic pattern also with
unusual ratio of two peaks. This result is in good concor-
dance with data from Ogilivie et al. (2005) who reported
that PCR-STR can identify mosaicism at level greater
than 15% 18. In our sample, the percentage of mosaicism
was 20%. When we compared this method to the chromo-
some analysis and karyotyping on cultured amniocytes,
it proved to be simpler and less expensive which is in con-
cordance with data from several other groups of authors.
Namely, the present study confirmed the results of
other, much larger studies demonstrating the usefulness
of PCR-STR method for detection of common autosomal
aneuploides (Down’s and Edwards’ syndrome). Nicolini
summarized the results from many authors with differ-
ent views of what might be the role of PCR-STR tech-
nique in prenatal diagnostics19. Almost all of them char-
acterised this method as being an economic and rapid
technique. More recently, Ogilvie (2003), Leung et al.
(2003) and Leung et al. (2004) suggested that the advan-
tages of PCR method clearly outweigh the disadvantages
and their suggestion was the replacement of conven-
tional prenatal cytogenetic analysis with PCR-STR me-
thod after positive serum screening for Down’s syndro-
me20–22. Mann et al. suggested that PCR-STR technique
could be also used as a stand-alone test in cases of ad-
vanced maternal age23. In conclusion, this study demon-
strated that trisomy 21 and 18 can consistently be identi-
fied by PCR-STR. Method is fast, sensitive and it is
possible prenatal identification of the two most frequent
trisomies within 3 days after collecting samples. Our set
of STR loci showed to be sufficient for diagnosis of
Down’s and Edward’s syndrome.
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TABLE 3
DATA FOR 6 SAMPLES WITH AUTOSOMAL ANOMALIES IN SCREENING OF 105 AMNIOTIC FLUIDS
Trisomy 18 (n=1) Trisomy 21 (n=4) Triploidy (n=1)
Locus
Sample
Locus
Sample
Locus
Sample
1 2 3 4 5 6
D18S51 1:1:1 D18S51 1:1 NI 1:1 1:1 D18S51 1:1:1
D18S535 2:1 D18S535 1:1 1:1 1:1 1:1 D18S535 1:1:1
D18S858 2:1 D18S858 NI 1:1 1:1 NI D18S858 1:1:1
D21S1435 1:1 D21S1435 1:1:1 2:1 1:1:1 NI D21S1435 1:1:1
D21S1411 1:1 D21S1411 2:1 1:1:1 1:1:1 NI D21S1411 1:1:1
D21S1414 1:1 D21S1414 2:1 1:1:1 1:1:1 1:1:1 D21S1414 1:1:1
1 – normal monoallelic, 1:1 – normal diallelic, 2:1 – trisomic diallelic, 1:1:1 – trisomic triallelic, NI – not informative
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BRZA PRENATALNA DIJAGNOSTIKA ANUPLOIDIJA 21 I 18 POMO]U METODE PCR-STR
S A @ E T A K
U ovom istra`ivanju su po prvi puta prikazani rezultati analize trisomija kromosoma 21 i 18 primjenom metode
PCR-STR (lan~ana reakcija polimerazom – kratka uzastopna ponavljanja) u hrvatskoj populaciji. Ciljevi ovog rada bili
su: (I) Istra`iti informativnost 6 lokusa STR (D18S51, D18S858, D18S535, D21S1435, D21S1411 i D21S1414) na uzorku
od 205 zdravih nesrodnih osoba; (II) Ocijeniti dijagnosti~ku vrijednost metode PCR-STR za navedene mikrosatelitske
lokuse; (III) Razviti protokol za brzo otkrivanje trisomija 21 i 18 primjenom metode PCR-STR kao rutinske metode u
prenatalnoj dijagnostici. Uzorci DNA amplificirani su metodom PCR, du`ina alela lokusa STR odre|ena je elektro-
forezom u automatskom laser sekvenceru (ALFexpress). Rezultati istra`ivanja su: (I) Svih 6 lokusa STR su informa-
tivni (68–85% osoba su bili heterozigoti); (II) Usporedba metode PCR-STR s metodom klasi~ne citogenetike nije poka-
zala ni la`no pozitivne, kao ni la`no negativne rezultate; (III) Prenatalnim pretra`ivanjem 105 uzoraka nekultiviranih
plodovih voda otkrivena je promjena u broju kromosoma kod 6 (5,7%) uzoraka.
K. Crkvenac-Gornik et al.: Prenatal Diagnosis Using PCR-STR Method, Coll. Antropol. 31 (2007) 3: 859–862
862
